Transmedics Group Inc’s filing revealed that its Chief Commercial Officer Khayal Tamer I unloaded Company’s shares for reported $93658.0 on Dec 02 ’24. In the deal valued at $86.40 per share,1,084 shares were sold. As a result of this transaction, Khayal Tamer I now holds 20,843 shares worth roughly $1.58 million.
Then, Khayal Tamer I sold 1,458 shares, generating $131,278 in total proceeds. Upon selling the shares at $90.04, the Chief Commercial Officer now owns 20,843 shares.
Before that, Basile Edward M sold 6,750 shares. Transmedics Group Inc shares valued at $563,994 were divested by the Director at a price of $83.55 per share. As a result of the transaction, Basile Edward M now holds 732 shares, worth roughly $55361.159999999996.
JP Morgan downgraded its Transmedics Group Inc [TMDX] rating to a Neutral from a an Overweight in a research note published on December 17, 2024; the price target was decreased to $75 from $116. A number of analysts have revised their coverage, including Needham’s analysts, who decreased its forecast for the stock in late November from “a Buy” to “a Hold”. Oppenheimer also remained covering TMDX and reiterated its “an Outperform” recommendation on October 29, 2024. Needham maintained its rating on October 29, 2024. It rated TMDX as “a Buy”.
Price Performance Review of TMDX
On Monday, Transmedics Group Inc [NASDAQ:TMDX] saw its stock jump 9.47% to $75.63. Over the last five days, the stock has gained 23.94%. Transmedics Group Inc shares have risen nearly 21.30% since the year began. Nevertheless, the stocks have risen 0.73% over the past one year. While a 52-week high of $177.37 was reached on 01/06/25, a 52-week low of $58.27 was recorded on 01/02/25. SMA at 50 days reached $78.02, while 200 days put it at $120.13.
Levels Of Support And Resistance For TMDX Stock
The 24-hour chart illustrates a support level at 72.73, which if violated will result in even more drops to 69.82. On the upside, there is a resistance level at 77.55. A further resistance level may holdings at 79.47. The Relative Strength Index (RSI) on the 14-day chart is 57.55, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 6.40, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 5.14%. Stochastics %K at 85.52% indicates the stock is a selling.
How much short interest is there in Transmedics Group Inc?
A steep rise in short interest was recorded in Transmedics Group Inc stocks on 2024-12-13, dropping by -0.34 million shares to a total of 8.64 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 8.98 million shares. There was a decline of -3.89%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 24, 2024 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $200 price target.
